Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.47

+0.3%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robohogs who wrote (21813)	11/2/2006 9:02:19 PM
From: NeuroInvestment	Read Replies (1) of 52153

Actually, it's resubmission in summer of 2008, not next summer, for IR capsules. A year later for either MR or IR for sleep maintenance (?) <<Now we see why PFE said "bye-bye.">> Wait--Pfizer had a significant role in this mess--how do they get out of taking the blame for this? Like NBIX shoved the indiplon NDA down Pfizer's throat? Not that NBIX is looking particularly praiseworthy as they dance around now.... NeuroInvestment

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next